Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
YolTech Therapeutics Administers First Patient Dose in IIT of YOLT-203, the World's First In Vivo Gene Editing Therapy for PH1 2024-08-22 18:00
Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Priorities 2024-08-22 17:04
Inaugural Process Innovation Asia Pacific to Drive Industry Transformation for South-East Asia's Chemicals and Pharmaceuticals 2024-08-22 15:30
China's First Approved KRAS G12C Inhibitor: Innovent Announces the Approval of Dupert® (Fulzerasib) by the National Medical Products Administration of China 2024-08-22 08:00
Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption 2024-08-21 09:00
WuXi XDC Reports Strong Business Updates with Superior Financial Results in 1H 2024: Poised for Future Growth 2024-08-20 23:05
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Second NDA Accepted by NPMA, locally advanced or metastatic EGFR-mutant NSCLC 2024-08-20 16:32
Infinitus Highlights Modernizing Traditional Prescriptions at ICMCM 2024-08-20 15:09
De Motu Cordis (DMC) Applauds ARS Pharma's FDA Approval of Neffy®, Expanding Patient Options to Needle-Free Epinephrine Delivery and Inspiring Confidence in Our Own Development Efforts 2024-08-16 18:00
Alphamab Oncology Reports 2024 Interim Results and Business Highlights 2024-08-16 11:18
Vimgreen Completes Enrollment of Its Phase 2 Clinical Trial Evaluating VG081821AC for the Treatment of Parkinson's Disease 2024-08-15 21:37
NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT 2024-08-15 13:43
Ivonescimab (PD-1/VEGF) Received Priority Review from China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC 2024-08-15 07:30
Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM" 2024-08-13 20:00
Docquity Drives Demand for SIT Pharma's Duo Probiotics in Thailand, Achieving 31% Sales Growth in 6 months 2024-08-13 10:00
Registrational Phase III Study of Lisaftoclax in Newly-Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome Cleared by China CDE 2024-08-13 09:52
Biosyngen's BRG01 Receives FDA Approval for Phase II Clinical Trial 2024-08-13 09:00
AI in the IVF Process is the Standard of Care at Virtus Fertility Centre Singapore 2024-08-13 08:44
Lynk Pharmaceuticals Announces Positive Results from Phase 1b Clinical Study of LNK01004 for the Treatment of Atopic Dermatitis 2024-08-13 08:00
Celltrion USA announces incorporation of adalimumab-aaty, a Humira® biosimilar, to the Costco Member Prescription Program 2024-08-13 07:46
1 18 19 20 21 22 412